Tirzepatide units: what the numbers on your Mounjaro pen actually mean

You're holding the pen and the numbers don't look like your prescription

Picture the moment: you've collected your Mounjaro KwikPen, you're about to take your weekly dose, and the unit window shows a figure that doesn't match the milligram number on your prescription. That disconnect is the thing most people are Googling when they search for tirzepatide units, and it has a straightforward explanation.

The Mounjaro KwikPen delivers a fixed volume of solution with each injection. Because Eli Lilly manufactures the pen in six strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg) each strength contains a different concentration of tirzepatide per millilitre. The unit markings on the dose window are a mechanical feature of the injector mechanism, not a separate clinical measurement. In practical terms, one unit on a 2.5 mg pen represents a different amount of medicine than one unit on a 15 mg pen, because the solutions have different concentrations. The prescriber works in milligrams; the pen's engineering works in volume units. Both are accurate descriptions of the same injection.

The Mounjaro SmPC on the eMC gives the precise concentration for each pen strength. If you want to cross-reference the unit reading against your prescribed mg dose, that document (or the printed Patient Information Leaflet inside your box) is the right place to start, not a general estimate.

Why six strengths, and what the titration schedule is actually doing

Tirzepatide treatment doesn't begin at a therapeutic dose. The 2.5 mg pen is the starting point purely because it gives the body time to adjust, reducing the likelihood of nausea and other gastrointestinal effects that are common when GLP-1 and GIP receptors are first activated. The prescriber then typically steps the dose upward in roughly four-week intervals, moving through 5 mg, 7.5 mg and so on toward the dose that produces the right clinical response for that individual.

Each step up means a pen with a different concentration, which is why the unit-to-mg relationship shifts across the schedule. Someone receiving guidance on tirzepatide dosing in units from their prescriber will find that the unit number they're dialling stays consistent within one pen box, but changes when the strength changes. This is by design. The KwikPen is a fixed-volume device; adjusting the concentration is how the manufacturer achieves different mg doses without requiring patients to dial different volumes.

It's worth noting that the progression isn't automatic. A prescriber reviews clinical suitability before each dose increase, at nume, that review happens before every repeat, not just at the start. The dose ladder exists to be climbed at the right pace for the person taking it, not at the fastest pace technically possible.

What to do if your unit reading looks wrong

A few situations cause genuine confusion. The most common: patients who transfer from one provider to another and find their new pen has slightly different markings, or those who receive a pen from a different batch and notice the window looks different to last time. Another scenario is mixing up pen strengths, collecting a 5 mg pen when a 7.5 mg was prescribed, for example, because both look similar in packaging.

If the unit window on your pen shows a reading you don't recognise, the right sequence is: check the outer box for the stated mg strength, check that it matches your prescription, then read the Patient Information Leaflet inside. If there's still a discrepancy, contact your prescribing team before injecting. At nume, the team is available seven days a week for exactly this kind of question, details on the contact page. Do not attempt to adjust the unit reading yourself or use a pen you're uncertain about.

There's a broader point here too. The growth in online sources selling tirzepatide pens (some counterfeit, some mislabelled) means that unfamiliar unit markings can occasionally signal a more serious problem than a packaging change. The MHRA has issued repeated warnings about fake weight-loss pens circulating through unregulated channels; you can verify any online pharmacy on the GPhC register and report suspect products via the Yellow Card scheme.

What this means in practice if you're considering Mounjaro

Most people asking about tirzepatide units are either already prescribed Mounjaro and checking their pen, or researching treatment ahead of a consultation. For the second group: the unit question resolves itself once you have a prescriber who explains which pen you're on and what to expect. The clinical detail that matters before treatment starts is eligibility, adults with a BMI of 30 or above, or 27 and above alongside a weight-related condition such as high blood pressure or type 2 diabetes, may be suitable. Lower thresholds apply for some ethnic backgrounds under UK guidance. The prescriber assesses the full picture, not the BMI figure alone.

You can read more about how Mounjaro works and what to expect as an overview, or look at tirzepatide's clinical background in more detail. If you're trying to understand a specific dose you've been prescribed (say, 25 units of tirzepatide or 50 units) there are dedicated pages covering what those readings correspond to by pen strength. A note on cost: pricing for private tirzepatide treatment has shifted considerably since Eli Lilly adjusted list prices in 2025; the story behind that price increase is worth reading before committing to any provider. Treatment cost and what's included varies, see the weight-loss treatments page for what's covered with a nume consultation. When you're ready to speak to someone, our prescribers review consultations the same day, a real clinician reads your answers, not a queuing system. Monday to Friday, if your form arrives before noon, dispatch goes out that day.